Ligand validation:4FRR

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4FRR_GOL_A_304	65%	79%	0.112	0.913	0.46	0.4	-	-	0	0	100%	1
4FRR_GOL_F_302	56%	88%	0.131	0.901	0.38	0.3	-	-	2	0	100%	1
4FRR_GOL_J_302	52%	83%	0.17	0.928	0.26	0.51	-	-	0	0	100%	1
4FRR_GOL_B_303	50%	77%	0.157	0.908	0.15	0.75	-	-	1	0	100%	1
4FRR_GOL_A_305	44%	85%	0.144	0.871	0.41	0.33	-	-	0	0	100%	1
4FRR_GOL_C_303	42%	53%	0.164	0.881	0.81	1	-	-	4	0	100%	1
4FRR_GOL_E_302	41%	76%	0.199	0.915	0.27	0.68	-	-	0	0	100%	1
4FRR_GOL_C_302	40%	78%	0.126	0.834	0.25	0.64	-	-	0	0	100%	1
4FRR_GOL_A_306	39%	61%	0.165	0.873	0.6	0.87	-	-	0	0	100%	1
4FRR_GOL_D_302	36%	87%	0.177	0.871	0.31	0.38	-	-	0	0	100%	1
4FRR_GOL_G_302	34%	88%	0.188	0.871	0.49	0.19	-	-	0	0	100%	1
4FRR_GOL_A_302	30%	62%	0.179	0.843	0.59	0.86	-	-	0	0	100%	1
4FRR_GOL_A_303	25%	35%	0.235	0.874	1.09	1.44	-	2	3	0	100%	1
4FRR_GOL_E_303	25%	78%	0.19	0.824	0.4	0.5	-	-	2	0	100%	1
4FRR_GOL_F_303	19%	72%	0.215	0.809	0.53	0.55	-	-	2	0	100%	1
4FRR_GOL_B_302	18%	85%	0.211	0.8	0.4	0.35	-	-	0	0	100%	1
4FRR_GOL_H_302	18%	72%	0.205	0.792	0.46	0.6	-	-	1	0	100%	1
4FRR_GOL_I_302	18%	72%	0.233	0.816	0.47	0.61	-	-	0	0	100%	1
4FRR_GOL_J_303	16%	77%	0.218	0.79	0.44	0.47	-	-	1	0	100%	1
4FRR_GOL_G_303	16%	82%	0.178	0.748	0.55	0.25	-	-	2	0	100%	1
4FRR_GOL_I_303	13%	72%	0.217	0.754	0.57	0.52	-	-	2	0	100%	1
4FRR_GOL_D_301	11%	80%	0.246	0.769	0.48	0.37	-	-	0	0	100%	1
4FRR_GOL_I_301	11%	63%	0.255	0.777	0.49	0.9	-	-	5	0	100%	1
4FRR_GOL_E_304	10%	70%	0.189	0.693	0.51	0.66	-	-	0	0	100%	1
4FRR_GOL_G_301	8%	83%	0.212	0.684	0.5	0.28	-	-	0	0	100%	1
4FRR_GOL_B_301	5%	88%	0.264	0.679	0.41	0.25	-	-	0	0	100%	1
6T9R_GOL_FFF_303	68%	69%	0.117	0.929	0.4	0.77	-	-	0	0	100%	1
2Y56_GOL_B_701	31%	62%	0.23	0.898	0.91	0.56	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.